Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The N7 position of the guanine base within nuclear double-stranded DNA is a critical nucleophilic site and a primary target for various chemotherapeutic agents. Due to its high electron density and accessibility within the major groove of the DNA helix, it is the most reactive position for electrophilic attack by alkylating agents and platinum-based coordination complexes (StatPearls, 2023). When drugs like cisplatin or cyclophosphamide bind to the N7 atom, they form stable covalent adducts that can further evolve into interstrand or intrastrand cross-links (PubMed, PMID: 11483377). These cross-links physically distort the DNA structure, effectively blocking the progression of DNA polymerase and RNA polymerase, thereby inhibiting DNA replication and transcription (NIH, PubChem). The resulting persistent DNA damage activates cellular stress responses and DNA damage checkpoints, ultimately triggering programmed cell death (apoptosis) in rapidly dividing cancer cells. While highly effective in oncology, the non-specific nature of these interactions leads to damage in healthy tissues, resulting in significant side effects such as bone marrow suppression and the potential for long-term mutagenic effects (Wikipedia, Alkylating antineoplastic agent).
Formation of covalent DNA adducts at the N7 position of guanine, leading to DNA cross-linking, inhibition of DNA synthesis, and induction of apoptosis.
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Guanine N7 position in nuclear double-stranded DNA (N7-G).